- Home
- GHG vs TERN Comparison
GHG vs TERN Comparison
Compare GHG & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHG
- TERN
- Stock Information
- Founded
- GHG 2004
- TERN 2017
- Country
- GHG China
- TERN United States
- Employees
- GHG N/A
- TERN N/A
- Industry
- GHG Hotels/Resorts
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- GHG Consumer Discretionary
- TERN Health Care
- Exchange
- GHG Nasdaq
- TERN Nasdaq
- Market Cap
- GHG 279.2M
- TERN 298.1M
- IPO Year
- GHG 2018
- TERN 2021
- Fundamental
- Price
- GHG $2.06
- TERN $2.40
- Analyst Decision
- GHG
- TERN Buy
- Analyst Count
- GHG 0
- TERN 5
- Target Price
- GHG N/A
- TERN $18.38
- AVG Volume (30 Days)
- GHG 17.7K
- TERN 1.3M
- Earning Date
- GHG 04-29-2025
- TERN 05-12-2025
- Dividend Yield
- GHG 4.05%
- TERN N/A
- EPS Growth
- GHG N/A
- TERN N/A
- EPS
- GHG 0.28
- TERN N/A
- Revenue
- GHG $201,166,731.00
- TERN N/A
- Revenue This Year
- GHG N/A
- TERN N/A
- Revenue Next Year
- GHG $8.78
- TERN N/A
- P/E Ratio
- GHG $7.41
- TERN N/A
- Revenue Growth
- GHG N/A
- TERN N/A
- 52 Week Low
- GHG $2.05
- TERN $1.87
- 52 Week High
- GHG $3.48
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- GHG 28.68
- TERN 40.98
- Support Level
- GHG $2.09
- TERN $2.22
- Resistance Level
- GHG $2.30
- TERN $2.43
- Average True Range (ATR)
- GHG 0.10
- TERN 0.24
- MACD
- GHG -0.02
- TERN 0.04
- Stochastic Oscillator
- GHG 2.08
- TERN 52.71
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.